Annual Congress Berlin 2001

Saturday, 22.09.2001
Sunday, 23.09.2001
Monday, 24.09.2001
Tuesday, 25.09.2001
Wednesday, 26.09.2001

Citations should be made in the following way: Authors. Title. Eur Respir J 2004; 18: Suppl. 33, abstract number.

Material from 2001:

3025 Abstracts

Material from 2001: Show

Smoking cessation: predictors and interventions

Oral Presentation
Chairs: L. J. Clancy (Dublin, Ireland), P. Tonnesen (Copenhagen, Denmark)

Download all media

Bupropion hydrochloride (Zyban™) is effective and well tolerated as an aid to smoking cessation - a multicountry study C. T. Bolliger, H. Gilljam, F. Lebargy, P. I. Van Spiegel, J. Edwards, A. Hider, R. Sweet (Cape Town, South Africa; Stockholm, Sweden; Reims, France; Amsterdam, The Netherlands; Greenford, United Kingdom)
Predictors for participation in smoking cessation. Results from a Danish population based intervention study Inter99 C. Pisinger, T. Jørgensen (Copenhagen, Denmark)
Does the score of a motivational questionnaire predict the short-term success of a smoking cessation programme? F. Pistelli, G. Matteelli, A. Scognamiglio, E. Polverino, L. Chiaffi, M. Desideri, E. Fornai, G. Lazzeri, G. Gronchi, J. Vitkute, S. Avino, L. Carrozzi, G. Viegi, C. Giuntini (Pisa, Italy)
Smoking cessation process and the age influence M. Barrueco, M. T. García, C. A. Jiménez Ruiz, J. A. Maderuelo, M. A. Hernández Mezquita, M. D. Plaza Martín (Salamanca, Madrid, Spain)
Bupropion treatment and cognitive behavioural therapy in a smoking cessation program C. Gratziou, K. Francis, A. Maragianni, Z. Athanasa, K. Efthimiou, T. Kalpakoglou, G. Katsani, A. Roussou, A. Kalantzi-Azizi, C. Roussos (Athens, Greece)
Bupropion hydrochloride sustained release (SR) is an effective and well tolerated aid to smoking cessation in smokers with cardiovascular disease - a multicountry study P. I. van Spiegel, K. Lewis, G. Seinost, C. Astbury, A. Hider, R. Sweet (Amsterdam, The Netherlands; Shrewsbury, Greenford, United Kingdom; Graz, Austria)
A.Mi.CO project: a network-based programme to improve smoking-cessation in GPs' office G. Invernizzi, G. Bettoncelli, G. Dambrosio, M. Zappa, M. Calzolari, R. Mazza, P. Paredi, R. Boffi (Florence, Milan, Italy; London, United Kingdom)
First demonstration of the good efficacy/safety ratio of Nicotinell® 1mg Lozenge (NL 1mg), a new form of nicotine substitution, by randomized clinical trial B. Dautzenberg, F. Ruff, M. Vaucher, P. Maillon, N. Jacob, J. L. Kienzler, D. Rentsch, A. Callens (Paris, Saint Etienne, Rueil-Malmaison, France; Nyon, Switzerland)